4D Molecular Therapeutics Inc (FDMT) Operatsion foyda koeffitsiyenti

4D Molecular Therapeutics Inc (FDMT) korporativ emblemasi va logotipi

4D Molecular Therapeutics DNKni organlarga aniq yetkazib berish orqali gen terapiyasi sohasida yetakchilik qilmoqda. Qat'iy ESG standartlari laboratoriya xavfsizligi va energiyaning samaradorligini ta'minlaydi. Tajribali rahbariyat tadqiqot va ishlanmalar (R&D) rejalariga qat'iy rioya qiladi. Operatsion marja tendentsiyasi subyektiv baholarsiz biznesning haqiqiy daromadliligini aks ettiradi va -226.00 ushbu ko'rsatkichning joriy bosqichdagi darajasini ko'rsatadi.

FDMT 4D Molecular Corp Operatsion marja (04.07.2022 - 20.11.2026)

4D Molecular Therapeutics (FDMT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning jamlanma tahlili:FDMT (4DMT)
4D Molecular Corp seriyali mahsuloti

4D Molecular Therapeutics (FDMT) uchun tushumning foiz ko'rsatkichi sifatidagi operatsion daromad darajasi biologlarning nufuzli xodimlar tarkibi bo'yicha xarajatlarni boshqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich foizlar va soliqlar to'lanishidan oldin asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Hisob-kitob operatsion natijaning kompaniyaning umumiy oborotiga nisbati asosida amalga oshiriladi. Marjaning pasayishi kredit risklarining ortishidan signal beradi, barqaror raqam esa qimmatbaho gen tadqiqotlarini moliyalashtirishda kapital barqarorligini tasdiqlaydi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik